OncoDecipher
ON
About
OncoDecipher is a life sciences company focused on developing novel diagnostic tools for cancer. Their proprietary technology analyzes silent mutations within cancer genomes to predict a patient's specific cancer type and their probability of survival, aiming to improve personalized treatment strategies.
Key facts
At-a-glance profile data
- Website
- oncdecipher.com
- Headquarters
- Cambridge, United States
- Founded
- 2015
- Total funding
- $1M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2015 | Seed | $1M | - |
Add first review
Frequently asked
How much funding has OncoDecipher raised?
OncoDecipher has raised a total of $1M in funding. The most recent round on record is Seed.
What is OncoDecipher's current status?
OncoDecipher's current operating status is: Inactive.